16 years of historical data (2011–2026) · Technology · Information Technology Services
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Science Applications International Corporation trades at 12.3x earnings, 23% below its 5-year average of 15.8x, sitting at the 0th percentile of its historical range. Compared to the Technology sector median P/E of 27.5x, the stock trades at a discount of 55%. On a free-cash-flow basis, the stock trades at 7.4x P/FCF, 39% below the 5-year average of 12.0x.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $4.2B | $4.7B | $5.5B | $6.9B | $5.8B | $4.8B | $5.6B | $5.2B | $3.0B | $3.4B | $3.7B |
| Enterprise Value | $4.3B | $4.8B | $7.8B | $9.0B | $8.2B | $7.4B | $8.2B | $7.1B | $4.8B | $4.3B | $4.6B |
| P/E Ratio → | 12.25 | 13.22 | 15.10 | 14.38 | 19.29 | 17.20 | 26.97 | 22.92 | 21.59 | 19.07 | 26.10 |
| P/S Ratio | 0.58 | 0.65 | 0.73 | 0.92 | 0.75 | 0.64 | 0.80 | 0.81 | 0.64 | 0.77 | 0.84 |
| P/B Ratio | 2.93 | 3.15 | 3.47 | 3.84 | 3.40 | 2.93 | 3.63 | 3.63 | 1.96 | 10.43 | 10.71 |
| P/FCF | 7.36 | 8.20 | 11.94 | 18.58 | 11.42 | 9.89 | 7.95 | 11.85 | 18.98 | 17.49 | 14.49 |
| P/OCF | 6.97 | 7.77 | 11.07 | 17.31 | 10.89 | 9.20 | 7.47 | 11.31 | 16.09 | 15.72 | 13.69 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Science Applications International Corporation's enterprise value stands at 6.4x EBITDA, 39% below its 5-year average of 10.5x. The Technology sector median is 17.4x, placing the stock at a 63% discount on an enterprise-value basis.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.66 | 1.04 | 1.21 | 1.07 | 1.00 | 1.16 | 1.11 | 1.03 | 0.96 | 1.03 |
| EV / EBITDA | 6.45 | 7.18 | 11.10 | 10.20 | 12.47 | 11.75 | 14.39 | 14.14 | 18.03 | 14.21 | 14.48 |
| EV / EBIT | 8.31 | 9.26 | 14.09 | 12.17 | 16.65 | 15.92 | 20.83 | 18.84 | 21.58 | 16.63 | 17.33 |
| EV / FCF | — | 8.26 | 17.04 | 24.41 | 16.19 | 15.29 | 11.55 | 16.21 | 30.85 | 22.00 | 17.73 |
Margins and return-on-capital ratios measuring operating efficiency
Science Applications International Corporation earns an operating margin of 7.1%. Operating margins have compressed from 10.0% to 7.1% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 23.3% indicates solid capital efficiency. ROIC of 14.2% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 12.0% | 12.0% | 11.9% | 11.7% | 11.5% | 11.6% | 11.2% | 11.1% | 10.0% | 9.2% | 9.9% |
| Operating Margin | 7.1% | 7.1% | 7.5% | 10.0% | 6.5% | 6.2% | 5.5% | 5.8% | 4.7% | 5.7% | 5.9% |
| Net Profit Margin | 4.9% | 4.9% | 4.8% | 6.4% | 3.9% | 3.7% | 3.0% | 3.5% | 2.9% | 4.0% | 3.2% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 23.3% | 23.3% | 21.5% | 27.3% | 18.0% | 17.4% | 14.0% | 15.4% | 14.9% | 53.0% | 39.2% |
| ROA | 6.8% | 6.8% | 6.9% | 8.8% | 5.3% | 4.8% | 4.0% | 4.9% | 4.1% | 8.7% | 6.9% |
| ROIC | 14.2% | 14.2% | 10.8% | 13.8% | 9.0% | 8.3% | 7.9% | 8.3% | 7.2% | 16.0% | 16.2% |
| ROCE | 12.5% | 12.5% | 14.1% | 17.3% | 11.4% | 10.5% | 9.7% | 10.2% | 8.7% | 18.3% | 18.4% |
Solvency and debt-coverage ratios — lower is generally safer
Science Applications International Corporation carries a Debt/EBITDA ratio of 0.3x, which is very conservative (89% below the sector average of 2.9x). Net debt stands at $35M ($217M total debt minus $182M cash). Interest coverage of 4.0x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.14 | 0.14 | 1.52 | 1.26 | 1.48 | 1.66 | 1.75 | 1.47 | 1.38 | 3.13 | 3.00 |
| Debt / EBITDA | 0.33 | 0.33 | 3.40 | 2.54 | 3.84 | 4.32 | 4.78 | 4.18 | 7.82 | 3.39 | 3.31 |
| Net Debt / Equity | — | 0.02 | 1.48 | 1.21 | 1.42 | 1.60 | 1.64 | 1.33 | 1.22 | 2.69 | 2.40 |
| Net Debt / EBITDA | 0.05 | 0.05 | 3.32 | 2.44 | 3.67 | 4.15 | 4.48 | 3.80 | 6.94 | 2.91 | 2.65 |
| Debt / FCF | — | 0.06 | 5.10 | 5.83 | 4.77 | 5.40 | 3.60 | 4.36 | 11.87 | 4.51 | 3.24 |
| Interest Coverage | 4.02 | 4.02 | 4.47 | 6.17 | 4.25 | 4.40 | 3.20 | 4.11 | 4.15 | 5.82 | 5.06 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.20x means Science Applications International Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 0.98x to 1.20x over the past 3 years.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.20 | 1.20 | 0.83 | 0.98 | 1.06 | 0.93 | 1.01 | 1.27 | 1.60 | 1.37 | 1.45 |
| Quick Ratio | 1.20 | 1.20 | 0.83 | 0.97 | 0.93 | 0.83 | 0.89 | 1.14 | 1.52 | 1.18 | 1.20 |
| Cash Ratio | 0.19 | 0.19 | 0.04 | 0.08 | 0.10 | 0.08 | 0.13 | 0.17 | 0.26 | 0.21 | 0.34 |
| Asset Turnover | — | 1.36 | 1.43 | 1.40 | 1.39 | 1.29 | 1.23 | 1.35 | 1.02 | 2.15 | 2.18 |
| Inventory Turnover | — | — | — | 2190.67 | 44.84 | 46.02 | 40.15 | 39.67 | 56.69 | 30.63 | 26.34 |
| Days Sales Outstanding | — | 42.87 | 48.80 | 44.82 | 44.35 | 50.10 | 49.76 | 62.88 | 82.26 | 55.23 | 44.29 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Science Applications International Corporation returns 12.1% to shareholders annually — split between a 1.6% dividend yield and 10.5% buyback yield. The payout ratio of 19.6% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 8.2% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.6% | 1.5% | 1.4% | 1.2% | 1.4% | 1.8% | 1.5% | 1.7% | 1.8% | 1.6% | 1.4% |
| Payout Ratio | 19.6% | 19.6% | 20.7% | 16.6% | 27.7% | 31.0% | 41.6% | 38.5% | 38.7% | 30.2% | 37.8% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 8.2% | 7.6% | 6.6% | 7.0% | 5.2% | 5.8% | 3.7% | 4.4% | 4.6% | 5.2% | 3.8% |
| FCF Yield | 13.6% | 12.2% | 8.4% | 5.4% | 8.8% | 10.1% | 12.6% | 8.4% | 5.3% | 5.7% | 6.9% |
| Buyback Yield | 10.5% | 9.4% | 10.2% | 5.6% | 4.6% | 4.7% | 0.6% | 3.8% | 2.3% | 5.5% | 4.8% |
| Total Shareholder Yield | 12.1% | 10.9% | 11.6% | 6.7% | 6.0% | 6.5% | 2.1% | 5.5% | 4.1% | 7.0% | 6.3% |
| Shares Outstanding | — | $47M | $51M | $54M | $56M | $58M | $59M | $59M | $44M | $45M | $46M |
Compare SAIC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $4B | 12.3 | 6.4 | 7.4 | 12.0% | 7.1% | 23.3% | 14.2% | 0.3 | |
| $17B | 12.1 | 9.0 | 10.5 | 17.7% | 12.3% | 30.9% | 17.1% | 2.5 | |
| $11B | 22.4 | 14.9 | 22.9 | 8.9% | 8.9% | 13.5% | 9.2% | 3.5 | |
| $13B | 10.5 | 10.6 | 14.2 | 54.8% | 11.4% | 91.2% | 24.3% | 2.7 | |
| $119B | 23.9 | 16.1 | 17.2 | 10.2% | 10.3% | 76.9% | 23.9% | 2.6 | |
| $238B | 35.6 | 21.0 | 30.0 | 20.1% | 10.0% | 10.4% | 6.7% | 3.1 | |
| $79B | 19.2 | 16.5 | 24.0 | 19.8% | 10.2% | 26.2% | 10.2% | 3.4 | |
| $94B | 22.5 | 16.8 | 23.7 | 15.1% | 10.2% | 17.7% | 12.5% | 1.6 | |
| $56B | 35.4 | 19.3 | 21.0 | 25.7% | 10.0% | 8.2% | 5.4% | 3.1 | |
| $3.1T | 30.3 | 19.4 | 42.9 | 68.8% | 45.6% | 33.3% | 24.9% | 0.7 | |
| $3.0T | 38.3 | 20.7 | 384.3 | 50.3% | 11.2% | 22.3% | 14.7% | 1.0 | |
| Technology Median | — | 27.5 | 17.4 | 19.8 | 48.6% | -0.5% | 2.4% | 2.9% | 2.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 16 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Leidos Holdings, Inc..
Start ComparisonQuick answers to the most common questions about buying SAIC stock.
Science Applications International Corporation's current P/E ratio is 12.3x. The historical average is 18.9x.
Science Applications International Corporation's current EV/EBITDA is 6.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.2x.
Science Applications International Corporation's return on equity (ROE) is 23.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 23.1%.
Based on historical data, Science Applications International Corporation is trading at a P/E of 12.3x. Compare with industry peers and growth rates for a complete picture.
Science Applications International Corporation's current dividend yield is 1.60% with a payout ratio of 19.6%.
Science Applications International Corporation has 12.0% gross margin and 7.1% operating margin.
Science Applications International Corporation's Debt/EBITDA ratio is 0.3x, indicating low leverage. A ratio below 2x is generally considered financially healthy.